https://www.selleckchem.com/pr....oducts/dorsomorphin-
Irregular treatment, the presence of comorbidities, and positive cultures after more than two months of treatment were associated with poor outcomes compared to successful ones (p0.05 for all). The multiple correspondence analyses grouped patients who were lost to follow-up, had HIV, and drug addiction, as well as patients with treatment failure, irregular treatment, and chronic obstructive pulmonary disease. The recognition of factors affecting treatment is essential and was associated with treatment outcomes in this seri